Author

Charles M. Strnad

Observed names: C Strnad, CHARLES STRNAD, Charles Strnad

Observed institutions: University of Oklahoma, Vanderbilt University Medical Center

OpenAlex ID: A5061289757

Peritoneal Carcinomatosis of Unknown Primary Site in Women

1989 · Charles M. Strnad, William W. Grosh, et al. · Annals of Internal Medicine · 100

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

2022 · Meletios A Dimopoulos, Paul G Richardson, et al. · The Lancet Haematology · 48

A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients with Advanced Large Bowel Cancer

1999 · Robert S. Witte, Stuart Lipsitz, et al. · Investigational New Drugs · 18

High-dose carboplatin, etoposide and cyclophosphamide with autologous bone marrow transplantation for the treatment of advanced malignancies: a phase I study.

1995 · R A Saez, R B Slease, et al. · PubMed · 6

Long-term Survival After Autologous Bone Marrow Transplantation for Metastatic Breast Carcinoma

1995 · RUBEN A. SAEZ, R. BRADLEY SLEASE, et al. · Southern Medical Journal · 6

Peritoneal Carcinomatosis of Unknown Primary Site in Women

2020 · Charles M. Strnad, William W. Grosh, et al. · Annals of Internal Medicine

Works count: 6

Citation count: 178

H-index: 5

I10-index: 3